|
|
Article: Novartis prevails in Lamisil patent dispute with Dr Reddy's.(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- September 13, 2004
CopyrightCOPYRIGHT 2004 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Novartis say that it has prevailed in its US patent infringement law suit with India's Dr Reddy's Laboratories regarding the Swiss drug major's widely-prescribed oral antifungal agent Lamisil (terbinafine HCl). Dr Reddy's has withdrawn its challenge to a Lamisil patent held by Novartis, conceding that it is valid, enforceable and had been infringed by the firm.
"While generics play an important and legitimate role in offering cost-effective therapeutic alternatives, strong patent protection remains essential to fostering continuous innovation that advance ...